Sector: Healthcare|Industry: Drug Manufacturers - General|Market Cap: $732.35B|Employees: 43K
Eli Lilly and Company is a global pharmaceutical company that discovers, develops, manufactures, and markets human pharmaceutical products. Its core business model revolves around research and development, generating revenue through sales of innovative medicines for diabetes, obesity, oncology, immunology, and neuroscience, with a presence in approximately 105 countries.
Highlights not available for this filing.
We're currently processing this filing. Would you like to be notified when the highlights are ready?